| Bioanalytical method validation: new FDA guidance vs. EMA guideline. Better or worse? M Kaza, M Karaźniewicz-Łada, K Kosicka, A Siemiątkowska, PJ Rudzki Journal of pharmaceutical and biomedical analysis 165, 381-385, 2019 | 123 | 2019 |
| Determination of clopidogrel metabolite (SR26334) in human plasma by LC–MS H Ksycinska, P Rudzki, M Bukowska-Kiliszek Journal of pharmaceutical and biomedical analysis 41 (2), 533-539, 2006 | 100 | 2006 |
| Quantitative evaluation of the matrix effect in bioanalytical methods based on LC–MS: A comparison of two approaches PJ Rudzki, E Gniazdowska, K Buś-Kwaśnik Journal of Pharmaceutical and Biomedical Analysis 155, 314-319, 2018 | 42 | 2018 |
| Rapid and simplified HPLC-UV method with on-line wavelengths switching for determination of capecitabine in human plasma E Piórkowska, M Kaza, J Fitatiuk, I Szlaska, T Pawiński, PJ Rudzki Die Pharmazie-An International Journal of Pharmaceutical Sciences 69 (7 …, 2014 | 32 | 2014 |
| Validated HPLC method for determination of temozolomide in human plasma. E Gilant, M Kaza, A Szlagowska, K Serafin-Byczak, PJ Rudzki Acta Poloniae Pharmaceutica 69 (6), 1347-1355, 2012 | 31 | 2012 |
| An overview of chromatographic methods coupled with mass spectrometric detection for determination of angiotensin-converting enzyme inhibitors in biological material PJ Rudzki, K Buś, H Ksycińska, K Kobylińska Journal of pharmaceutical and biomedical analysis 44 (2), 356-367, 2007 | 27 | 2007 |
| Cloud-point extraction is compatible with liquid chromatography coupled to electrospray ionization mass spectrometry for the determination of bisoprolol in human plasma J Giebułtowicz, G Kojro, K Buś-Kwaśnik, PJ Rudzki, R Marszałek, A Leś, ... Journal of Chromatography A 1423, 39-46, 2015 | 25 | 2015 |
| Simplified LC–MS/MS method enabling the determination of azithromycin in human plasma after a low 100 mg dose administration M Filist, K Buś-Kwaśnik, H Ksycińska, PJ Rudzki Journal of pharmaceutical and biomedical analysis 100, 184-189, 2014 | 25 | 2014 |
| Validated HPLC method for determination of cefuroxime in human plasma. A Szlagowska, M Kaza, PJ Rudzki Acta Poloniae Pharmaceutica 67 (6), 677-681, 2010 | 24 | 2010 |
| Determination of sunitinib in human plasma using liquid chromatography coupled with mass spectrometry J Musijowski, E Piórkowska, PJ Rudzki Journal of separation science 37 (19), 2652-2658, 2014 | 22 | 2014 |
| Application of confidence intervals to bioanalytical method validation-drug stability in biological matrix testing PJ Rudzki, A Leś Acta Pol Pharm 65, 743-747, 2008 | 22 | 2008 |
| Low-oxidation-potential thiophene-carbazole monomers for electro-oxidative molecular imprinting: Selective chemosensing of aripiprazole M Gajda, R Rybakiewicz, M Cieplak, T Żołek, D Maciejewska, E Gilant, ... Biosensors and Bioelectronics 169, 112589, 2020 | 21 | 2020 |
| Sensitive single quadrupole LC/MS method for determination of lapatinib in human plasma J Musijowski, M Filist, PJ Rudzki Acta Pol. Pharm 71 (6), 1029-1036, 2014 | 20 | 2014 |
| Matrix effect screening for cloud-point extraction combined with liquid chromatography coupled to mass spectrometry: bioanalysis of pharmaceuticals G Kojro, PJ Rudzki, DM Pisklak, J Giebułtowicz Journal of Chromatography A 1591, 44-54, 2019 | 15 | 2019 |
| Validated LC-MS method for determination of tamsulosin in human plasma and its application to pharmacokinetic study H Ksycinska, PJ Rudzki, A Sarosiek Acta Poloniae Pharmaceutica 63 (5), 417-419, 2006 | 15 | 2006 |
| Comprehensive graphical presentation of data from incurred sample reanalysis PJ Rudzki, P Biecek, M Kaza Bioanalysis 9 (12), 947-956, 2017 | 14 | 2017 |
| Incurred sample reanalysis: time to change the sample size calculation? PJ Rudzki, P Biecek, M Kaza The AAPS Journal 21 (2), 28, 2019 | 12 | 2019 |
| Bioequivalence study of 2.5 mg film-coated bisoprolol tablets in healthy volunteers K Buś-Kwaśnik, PJ Rudzki, H Ksycińska, A Leś, K Serafin-Byczak, ... Polish Heart Journal (Kardiologia Polska) 75 (1), 48-54, 2017 | 10 | 2017 |
| Is a deuterated internal standard appropriate for the reliable determination of olmesartan in human plasma? E Piórkowska, J Musijowski, K Buś-Kwaśnik, PJ Rudzki Journal of Chromatography B 1040, 53-59, 2017 | 9 | 2017 |
| Determination of duloxetine in human plasma with proven lack of influence of the major metabolite 4-hydroxyduloxetine M Kaza, E Gilant, M Filist, I Szlaska, T Pawiński, PJ Rudzki Clinical Biochemistry 47 (13-14), 1313-1315, 2014 | 9 | 2014 |
Michal KazaBioanalytical Laboratory @ Celon Pharma SAZweryfikowany adres z celonpharma.com
